Isabel T. Rubio

12.9k total citations · 1 hit paper
132 papers, 4.5k citations indexed

About

Isabel T. Rubio is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Isabel T. Rubio has authored 132 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Cancer Research, 69 papers in Pathology and Forensic Medicine and 50 papers in Oncology. Recurrent topics in Isabel T. Rubio's work include Breast Cancer Treatment Studies (100 papers), Breast Lesions and Carcinomas (67 papers) and Breast Implant and Reconstruction (40 papers). Isabel T. Rubio is often cited by papers focused on Breast Cancer Treatment Studies (100 papers), Breast Lesions and Carcinomas (67 papers) and Breast Implant and Reconstruction (40 papers). Isabel T. Rubio collaborates with scholars based in Spain, United States and Italy. Isabel T. Rubio's co-authors include Fátima Cardoso, Philip Poortmans, Frédérique Penault‐Llorca, Shinji Ohno, Sophia Zackrisson, Elżbieta Senkus, S. Kyriakides, V. Suzanne Klimberg, Soheila Korourian and Judith Balmañà and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Isabel T. Rubio

123 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2019 1.4k citations Fátima Cardoso, Frédérique Penault‐Llorca et al. Annals of Oncology profile →

Peers

Isabel T. Rubio

PFM

ONCOL

SURGE

Irene Wapnir United States

Julia S. Wong United States

R. Douglas Macmillan United Kingdom

Nora Hansen United States

Bernd Gerber Germany

Brigitte Sigal‐Zafrani France

S. Eva Singletary United States

Elisa Port United States

Toralf Reimer Germany

Gordon F. Schwartz United States

Irene Wapnir United States

Isabel T. Rubio

2.5k ×0.9

1.6k ×0.9

PFM

1.8k ×1.0

ONCOL

1.2k ×1.1

SURGE

533 ×0.9

Citations per year, relative to Isabel T. Rubio Isabel T. Rubio (= 1×) peers Irene Wapnir

Countries citing papers authored by Isabel T. Rubio

Since Specialization

Citations

This map shows the geographic impact of Isabel T. Rubio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel T. Rubio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel T. Rubio more than expected).

Fields of papers citing papers by Isabel T. Rubio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel T. Rubio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel T. Rubio. The network helps show where Isabel T. Rubio may publish in the future.

Co-authorship network of co-authors of Isabel T. Rubio

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel T. Rubio. A scholar is included among the top collaborators of Isabel T. Rubio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel T. Rubio. Isabel T. Rubio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Groheux, David, Sofia C. Vaz, Lioe‐Fee de Geus‐Oei, et al.. (2025). [ ¹⁸ F]-Labeled Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Staging and Restaging Patients With Breast Cancer. Journal of Clinical Oncology. 43(17). 1942–1947.

Catanuto, Giuseppe, Damiano Gentile, Federica Martorana, et al.. (2025). Clinico-pathological features predicting indication to mastectomy in breast cancer patients achieving complete response after neoadjuvant therapy: A retrospective analysis of the EUSOMA database. European Journal of Surgical Oncology. 51(6). 109643–109643. 2 indexed citations

Margenthaler, Julie, Youssef H. Zeidan, Rosa Di Micco, et al.. (2025). 2101 Local management of second breast cancer event after primary breast conserving therapy: International DELPHI consensus. Radiotherapy and Oncology. 206. S508–S509.

Parks, Ruth, Lorenza Marotti, Antonio Ponti, et al.. (2024). Uptake of post-mastectomy immediate breast reconstruction in older women – A real-world analysis from the European Society of Breast Cancer Specialists (EUSOMA) certified breast centres. European Journal of Cancer. 200. 113776–113776.

Vaz, Sofia C., J.P. Pilkington Woll, Fátima Cardoso, et al.. (2024). Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer. European Journal of Nuclear Medicine and Molecular Imaging. 51(9). 2706–2732. 30 indexed citations

Groheux, David, Sofia C. Vaz, Philip Poortmans, et al.. (2024). Role of [18F]FDG PET/CT in patients with invasive breast carcinoma of no special type: Literature review and comparison between guidelines. The Breast. 78. 103806–103806. 2 indexed citations

Esgueva, Antonio, Mariano Tomatis, Antonio Ponti, et al.. (2024). Axillary surgery trends for breast cancer after neoadjuvant treatment: a report from the EUSOMA multi-institutional European database. European Journal of Surgical Oncology. 50(2). 107370–107370.

Cardoso, Fátima, Amelia McCartney, Antonio Ponti, et al.. (2023). European Society of Breast Cancer Specialists/Advanced Breast Cancer Global Alliance quality indicators for metastatic breast cancer care. European Journal of Cancer. 187. 105–113. 7 indexed citations

Rubio, Isabel T., Lynda Wyld, Lorenza Marotti, et al.. (2023). European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO. European Journal of Surgical Oncology. 50(1). 107292–107292. 22 indexed citations

10.

Banys‐Paluchowski, Maggie, Isabel T. Rubio, Nina Ditsch, et al.. (2023). Real de-escalation or escalation in disguise?. The Breast. 69. 249–257. 8 indexed citations

11.

Esgueva, Antonio, et al.. (2023). Intraoperative ultrasound margin evaluation as a tool to reduce positive superficial margins in nipple and skin sparing mastectomy in breast cancer patients. European Journal of Surgical Oncology. 49(11). 107049–107049. 2 indexed citations

12.

Calvo, Felipe A., Javier Serrano, Mauricio Cambeiro, et al.. (2022). Intra-Operative Electron Radiation Therapy: An Update of the Evidence Collected in 40 Years to Search for Models for Electron-FLASH Studies. Cancers. 14(15). 3693–3693. 10 indexed citations

13.

Schmidt, Marjanka K., Anne Brédart, David Cameron, et al.. (2022). EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic mastectomy. European Journal of Cancer. 181. 79–91. 8 indexed citations

14.

Mattos‐Arruda, Leticia De, Javier Cortés, Daniel Guimarães Tiezzi, et al.. (2021). The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers. npj Breast Cancer. 7(1). 73–73. 7 indexed citations

15.

Pascual, Tomás, Mafalda Oliveira, Patricia Villagrasa, et al.. (2021). Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial. npj Breast Cancer. 7(1). 145–145. 8 indexed citations

16.

Esgueva, Antonio, et al.. (2020). Leveraging the increased rates of pathologic complete response after neoadjuvant treatment in breast cancer to de‐escalate surgical treatments. Journal of Surgical Oncology. 123(1). 71–79. 7 indexed citations

17.

Espinosa-Bravo, Martín, Antonio Esgueva, Vicente Peg, et al.. (2016). Different Prognostic Implications of Residual Disease After Neoadjuvant Treatment: Impact of Ki 67 and Site of Response. Annals of Surgical Oncology. 23(12). 3831–3837. 26 indexed citations

18.

Cortadellas, Tomás, Octavi Córdoba, Martín Espinosa-Bravo, et al.. (2011). Electrothermal bipolar vessel sealing system in axillary dissection: A prospective randomized clinical study. International Journal of Surgery. 9(8). 636–640. 28 indexed citations

19.

Balmañà, Judith, Orland Dı́ez, Isabel T. Rubio, & M. Castiglione. (2010). BRCA in breast cancer: ESMO Clinical Practice Guidelines. Annals of Oncology. 21. v20–v22. 164 indexed citations

20.

Henry‐Tillman, Ronda, Soheila Korourian, Isabel T. Rubio, et al.. (2002). Intraoperative touch preparation for sentinel lymph node biopsy: A 4-year experience. Annals of Surgical Oncology. 9(4). 333–339. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact